RXULTI 0,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Otsuka Pharmaceutical Netherlands B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: abf25d20968eae42
Drug Cima Aemps Name: RXULTI 0,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 1181294002
Holder Company Name: Otsuka Pharmaceutical Netherlands B.V.
Marketing Company Name: Otsuka Pharmaceutical S.A.
Holder Company Detail Path: /organization/otsuka-pharmaceutical-netherlands-b-v
Authorization Date: 2025-04-09
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 0,5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Otsuka Pharmaceutical Netherlands B.V.
Company Detail Path: /organization/otsuka-pharmaceutical-netherlands-b-v

BREXPIPRAZOL

0,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 9, 2025

Approval ID

abf25d20968eae42

Type

Standard